Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 18
Review
A Profile of Avelumab Plus Axitinib in the Treatment of Renal Cell Carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,935 | Dovepress* | 5,475+ | 243 | 5,718 | |
| PubMed Central* | 460 | 121 | 581 | ||
| Totals | 5,935 | 364 | 6,299 | ||
| *Since 8 July 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar